Results

Total Results: 3,142 records

Showing results for "disease".

181. Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cad-women-diagnosis-future/research
     December 01, 2019 - : Noninvasive Technologies for the Diagnosis of Coronary Artery Disease … Excerpt Cardiovascular disease is the leading cause of mortality for women in the United States. … Heart Association (AHA), approximately one in three female adults have some form of cardiovascular disease … AHA suggests there is evidence showing that women at risk for coronary artery disease (CAD) are less … Project Timeline Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future

182. Iron | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/iron
     January 14, 2013 - Some people have an inherited disease called hemochromatosis . … Centers for Disease Control and Prevention Source https://medlineplus.gov/iron.html Products … 2013 Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … 2012 Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … Outcomes in End-Stage Renal Disease (ESRD) Back to Top

183. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment-future/research
     December 01, 2019 - Evidence Reports Treatment Strategies for Women With Coronary Artery Disease … SHARE: Treatment Strategies for Women With Coronary Artery Disease … Excerpt Cardiovascular disease remains the leading cause of death among women in the United States. … More than 500,000 women die of cardiovascular disease each year, exceeding the number of deaths in men … Project Timeline Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs

184. Malabsorption Syndromes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/malabsorption-syndromes
     July 26, 2016 - Causes of malabsorption syndromes include Celiac disease Lactose intolerance Short bowel syndrome … You might need the surgery if you have a problem with the small intestine from a disease, injury, or … Whipple disease, a rare bacterial infection Genetic diseases Certain medicines Symptoms of different … of the Evidence Systematic Review Archived January 28, 2016 Diagnosis of Celiac Disease … Research Protocol Archived June 11, 2014 Diagnosis of Celiac Disease

185. Executive Summary_The Effect of Protein Intake on Health: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/effect-protein-intake-executive-summary.pdf
     November 01, 2024 - , kidney disease, and sarcopenia risks is insufficient and inconclusive. … for bone, kidney disease, and sarcopenia diagnostic components. … reference value for chronic disease risk reduction. … Limitations Our systematic review had several strengths, including a unique emphasis on multiple chronic diseases … and sarcopenia, which may not fully reflect the presence and progression of chronic diseases, diverse

186. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease 1 Comparative Effectiveness … artery disease (CAD) are substantial. … Guideline states that diagnostic testing is most valuable when the pretest probability of ischemic heart diseases … Guideline states that diagnostic testing is most valuable when the pretest probability of ischemic heart diseases … Robbins & Cotran Pathophysiologic Basis of Disease. 9th ed. Philadelphia: W. B.

187. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/juvenile-arthritis-dmards/research
     December 01, 2019 - (JIA) SHARE: Disease-Modifying … Structured Abstract Objectives To summarize the benefits and harms of disease-modifying antirheumatic … Project Timeline Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic … Research Protocol Dec 20, 2024 The Performance of Fusion Procedures for Degenerative Disease … Nov 01, 2024 The Association Between Outcomes and Dental Services in Persons With Autoimmune Disease

188. Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
     December 01, 2019 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease … Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease … Chronic renal disease affects more than 26 million Americans and is the cause of significant morbidity … Anemia, a common complication, conveys significant risk for cardiovascular disease, faster progression … In fact, most patients with chronic renal disease become anemic.

189. Treatment Intensification in Type 2 Diabetes Mellitus | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-treatment/abstract
     December 01, 2019 - patients with type 2 diabetes mellitus (DM) may have other major illnesses including heart and kidney disease … versus treatment with an additional oral antidiabetic agent, benefits patients with cardiovascular disease … (CVD) and/or chronic kidney disease (CKD). … CKD; b) progression of CVD (acute myocardial infarction and stroke), CKD (including End Stage Renal Disease … Expected date of project completion: Winter 2013 EHC Priority Condition(s): Diabetes, Cardiovascular Disease

190. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/psoriasis-chronic/research-protocol
     December 01, 2019 - oral solution, intra-lesional) ‡ Approved for use in endocrine and rheumatic disorders; collagen diseases … ; dermatologic diseases including pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme … mycosis fungoides, severe psoriasis, and severe seborrheic dermatitis; allergic states; ophthalmic diseases … ; respiratory disease; hematologic disorders; neoplastic disease; edematous states; gastrointestinal … disease Table 4.

191. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults Laurel … ADHD Medications and Risk of Serious Coronary Heart Disease in Young and Middle-Aged Adults. … rises due to the increasing prevalence of cardiovascular disease risk factors. … Use of disease risk scores in pharmacoepidemiologic studies. … Prediction of coronary heart disease using risk factor categories.

192. Summary Variables in Observational Research: Propensity Scores and Disease Risk Scores | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/observational-research-scores/research
     January 01, 2019 - groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators of other diseases … However, the disease risk score estimates the probability or rate of disease (or outcome) occurrence … The association between exposure and disease (or outcome) is then estimated adjusting for the disease … Disease Risk Score Calculation Given that the disease risk score estimates the probability of disease … Disease Risk Score Assessment The disease risk score is often categorized into groups such that the

193. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
     October 01, 2019 - Key Messages Conclusions are based on studies that enrolled patients with moderate to high disease … activity at baseline as measured with Disease Activity 28 Scores and may not apply to the general RA … Insufficient information was available about treatment options for patient subgroups, such as disease … All included studies enrolled patients with moderate to high disease activity at baseline as measured … Data about subgroups (based on disease activity, prior therapy, demographics, and the presence of other

194. Comparative Effectiveness of Treatments for Restless Legs Syndrome | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/restless-legs/research-protocol
     December 01, 2019 - If the disease progresses, symptoms may occur earlier in the day and intensify even further at night … to assess disease severity and treatment-induced changes in disease status. … Yet, the disease is chronic, often requiring life-long treatment. … definition of clinically significant change in disease status used in individual studies. … Pre-planned sensitivity analyses include: age, disease severity, iron status, and comorbidities.

195. Executive Summary_Systematic Review: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
     March 01, 2025 - heart disease (CHD). … As intake over a lifespan may influence the development of these chronic diseases, studies following … Cardiovascular disease mortality in the Americas: current trends and disparities. … Recent trends in cardiovascular disease deaths: a state specific perspective. … Diet, nutrition and the prevention of chronic diseases.

196. Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/gerd-2005/research
     December 01, 2019 - Reports Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease … Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease … examines alternatives for managing the chronic symptoms of uncomplicated gastroesophageal reflux disease … Project Timeline Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease … Research Protocol Dec 20, 2024 The Performance of Fusion Procedures for Degenerative Disease

197. The Performance of Fusion Procedures for Degenerative Disease of the Lumbar Spine (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/lumbar-spinal-fusion-key-question.pdf
     January 01, 2023 - The Performance of Fusion Procedures for Degenerative Disease of the Lumbar Spine 1 The Performance … of Fusion Procedures for Degenerative Disease of the Lumbar Spine DRAFT KEY QUESTIONS (KQs) … KQ4: Among patients with chronic low-back pain resulting from degenerative disease of the lumbar spine … Trends in Lumbar Fusion Procedure Rates and Associated Hospital Costs for Degenerative Spinal Diseases … rate and influence of surgery-related factors in lumbar interbody arthrodesis for degenerative spine diseases

198. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … cannot be determined at this time. 1 The JMIC-B (Japan Multicenter Investigation for Cardiovascular Diseases-B

199. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/copd-management/research
     November 01, 2017 - Home Evidence Reports Mortality Risk in Chronic Obstructive Pulmonary Disease … SHARE: Mortality Risk in Chronic Obstructive Pulmonary Disease … Participants Patients with a diagnosis of chronic obstructive pulmonary disease that were 45 years … adn Main Results Primary outcome measures were all-cause mortality, chronic obstructive pulmonary disease … exacerbations and chronic obstructive pulmonary disease-related hospitalizations.

200. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/report
     June 01, 2021 - For three chronic conditions (coronary artery disease, heart failure, and asthma), we found a possible … , diabetes prevention, sleep apnea, stroke, and Parkinson’s disease). … patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases … automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases … , and chronic obstructive pulmonary disease.